We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+40.76%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$1.73B
AUM Growth
+$486M
Cap. Flow
+$57.8M
Cap. Flow %
3.35%
Top 10 Hldgs %
31.64%
Holding
230
New
36
Increased
82
Reduced
35
Closed
4

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$27.3M
2
SIVB
SVB Financial Group
SIVB
+$12.4M
3
SHOP icon
Shopify
SHOP
+$10.5M
4
RP
RealPage, Inc.
RP
+$7.11M
5
ZD icon
Ziff Davis
ZD
+$6.94M

Top Sells

Rank Stock Value
1
WW
WW International
WW
+$15.6M
2
IRM icon
Iron Mountain
IRM
+$11M
3
SCHW
Charles Schwab
SCHW
+$8.89M
4
DXCM icon
DexCom
DXCM
+$3.46M
5
ABMD
Abiomed Inc
ABMD
+$3.02M

Sector Composition

Rank Sector Weight
1 Healthcare 25.44%
2 Technology 19.91%
3 Financials 19.27%
4 Communication Services 9.98%
5 Consumer Discretionary 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INGN icon
151
Inogen
INGN
$175M
$513K 0.03%
14,438
-9,569
-40% -$403K
YUMC icon
152
Yum China
YUMC
$16.5B
$507K 0.03%
10,541
-51
-0.5% -$2.4K
AON icon
153
Aon
AON
$76.5B
$501K 0.03%
+2,600
New +$484K
WFC icon
154
Wells Fargo
WFC
$261B
$477K 0.03%
18,614
+3,576
+24% +$97.8K
D icon
155
Dominion Energy
D
$60.8B
$474K 0.03%
5,839
– –
IQV icon
156
IQVIA
IQV
$38.7B
$469K 0.03%
+3,307
New +$448K
UPS icon
157
United Parcel Service
UPS
$88.6B
$455K 0.03%
4,089
+1,052
+35% +$105K
GSK icon
158
GSK
GSK
$104B
$450K 0.03%
8,817
– –
OTIS icon
159
Otis Worldwide
OTIS
$27.4B
$447K 0.03%
+7,857
New +$407K
MAR icon
160
Marriott International
MAR
$98.3B
$443K 0.03%
5,170
+716
+16% +$62.2K
VRSK icon
161
Verisk Analytics
VRSK
$25.4B
$426K 0.02%
2,500
– –
SGOL icon
162
abrdn Physical Gold Shares ETF
SGOL
$6.91B
$424K 0.02%
24,740
– –
TXN icon
163
Texas Instruments
TXN
$252B
$411K 0.02%
3,240
– –
EPD icon
164
Enterprise Products Partners
EPD
$82.3B
$409K 0.02%
22,518
– –
STT icon
165
State Street
STT
$50.6B
$408K 0.02%
6,423
+1,726
+37% +$104K
USB icon
166
US Bancorp
USB
$98.2B
$399K 0.02%
10,826
+3,956
+58% +$141K
EMR icon
167
Emerson Electric
EMR
$83.9B
$397K 0.02%
6,406
-1,394
-18% -$79.2K
K
168
DELISTED
Kellanova
K
$394K 0.02%
6,347
– –
UN
169
DELISTED
Unilever NV New York Registry Shares
UN
$392K 0.02%
7,351
+717
+11% +$36.4K
LIN icon
170
Linde
LIN
$221B
$390K 0.02%
1,840
– –
VCSH icon
171
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$385K 0.02%
4,656
– –
WIX icon
172
WIX.com
WIX
$2.3B
$384K 0.02%
+1,500
New +$266K
BABA icon
173
Alibaba
BABA
$293B
$382K 0.02%
+1,769
New +$368K
DTE icon
174
DTE Energy
DTE
$29.5B
$376K 0.02%
4,107
– –
PCTY icon
175
Paylocity
PCTY
$7.38B
$365K 0.02%
+2,500
New +$291K
5 6
7
8 9

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Chicago Capital held 230 positions worth $1.73B, up 39% from $1.24B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Chicago Capital deployed $57.8M of net new capital in Q2 2020, opening 36 new positions and adding to 82 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 430,824 shares worth $30.1M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was WW International, an estimated $15.6M trimmed.

  • Chicago Capital's largest Q2 2020 buy was Ligand Pharmaceuticals: 430,824 shares worth $30.1M.
  • Chicago Capital added most to SVB Financial Group in Q2 2020, an estimated $12.4M increase.
  • Chicago Capital's biggest Q2 2020 reduction was WW International, cutting an estimated $15.6M.
  • Chicago Capital fully exited Royal Dutch Shell PLC ADS Class A in Q2 2020, selling an estimated $276K.
  • Chicago Capital's ten largest holdings make up 32% of its $1.73B portfolio in Q2 2020.
  • Chicago Capital opened 36 new positions and closed 4 in Q2 2020.
  • Chicago Capital's portfolio value rose 39% quarter-over-quarter to $1.73B.

Based on Chicago Capital's 13F filing for Q2 2020, filed 29 Jul 2020.